Boston Scientific (BSX)

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.

Company profile

Ticker

BSX

Exchange

NYSE

Website

www.bostonscientific.com/

CEO

Michael Mahoney

Incorporated

Delaware

Location

Massachusetts

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Surgical & Medical Instruments & Apparatus

3M • Baxter International • Stryker • Becton Dickinson & Co. • Teleflex • Resmed • West Pharmaceutical Services • Haemonetics • Hill-Rom • Integra Lifesciences ...

SEC CIK

0000885725

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Acurate Industria e Comercio Ltda. • American Medical Systems Europe B.V. • Baylis Medical UK Limited • BAYLIS Medical (Deutschland) GmbH • Baylis Medical Company Inc. • Baylis Medical France S.A.R.L. • Baylis Medical USA Inc. • Biocompatibles UK Limited • Biocompatibles, Inc. • Boston Scientific (Malaysia) Sdn. Bhd. ...

IRS number

42695240

BSX stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$61.43

Low target

$59.00

High target

$64.00

Latest filings (excl ownership)

View all

3 Aug 23

Boston Scientific Announces Results for Second Quarter 2023

27 Jul 23

8-K

Departure of Directors or Certain Officers

Conflict minerals disclosure

25 May 23

8-K

Submission of Matters to a Vote of Security Holders

4 May 23

Boston Scientific Announces Results for First Quarter 2023

Transcripts

View all

BSX

Earnings call transcript

2023 Q2

27 Jul 23

BSX

Earnings call transcript

2022 Q4

1 Feb 23

BSX

Earnings call transcript

2022 Q3

26 Oct 22

BSX

Earnings call transcript

2022 Q2

27 Jul 22

BSX

Earnings call transcript

2022 Q1

27 Apr 22

BSX

Earnings call transcript

2021 Q4

2 Feb 22

BSX

Earnings call transcript

2021 Q3

27 Oct 21

BSX

Earnings call transcript

2021 Q2

27 Jul 21

BSX

Earnings call transcript

2021 Q1

28 Apr 21

BSX

Earnings call transcript

2020 Q4

3 Feb 21

Latest ownership filings

View all

Joseph Michael Fitzgerald

21 Sep 23

144

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

29 Aug 23

144

Notice of proposed sale of securities

28 Aug 23

Financial summary

Financial statements Chart BSX financial data

Quarter (USD)	Jun 23	Mar 23	Dec 22	Sep 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	620.00 mm	620.00 mm	620.00 mm	620.00 mm	620.00 mm	620.00 mm
Cash burn (monthly)	47.67 mm	(no burn)	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	140.04 mm	n/a	n/a	n/a	n/a	n/a
Cash remaining	479.96 mm	n/a	n/a	n/a	n/a	n/a
Runway (months of cash)	10.1	n/a	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2023

BSX institutional ownership history Ownership history

89.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	1008	962	+4.8%
Opened positions	130	137	-5.1%
Closed positions	84	78	+7.7%
Increased positions	380	377	+0.8%
Reduced positions	340	306	+11.1%

13F shares	Current	Prev Q	Change
Total value	69.89 tn	63.48 tn	+10.1%
Total shares	1.30 bn	1.28 bn	+1.7%
Total puts	4.99 mm	3.22 mm	+55.0%
Total calls	4.55 mm	2.89 mm	+57.2%
Total put/call ratio	1.1	1.1	-1.4%

Largest owners	Shares	Value	Change
BLK Blackrock	137.49 mm	$7.44 tn	+0.1%
Vanguard	122.24 mm	$6.61 tn	+1.7%
FMR	117.88 mm	$6.38 tn	+3.6%
Massachusetts Financial Services	69.14 mm	$3.74 tn	-13.1%
STT State Street	63.19 mm	$3.42 tn	+1.9%
Wellington Management	39.74 mm	$2.15 tn	-14.5%
Primecap Management	37.43 mm	$2.02 tn	-2.3%
BAC Bank Of America	26.59 mm	$1.44 tn	+8.0%
Geode Capital Management	26.05 mm	$1.40 tn	+2.8%
Bollard	23.68 mm	$1.28 tn	-1.8%

Largest transactions	Shares	Bought/sold	Change
JPM JPMorgan Chase & Co.	23.16 mm	-10.51 mm	-31.2%
Massachusetts Financial Services	69.14 mm	-10.40 mm	-13.1%
Millennium Management	10.22 mm	+10.22 mm	NEW
Wellington Management	39.74 mm	-6.76 mm	-14.5%
IVZ Invesco	14.65 mm	+5.47 mm	+59.5%
Winslow Capital Management	4.40 mm	+4.40 mm	NEW
Voya Investment Management	9.63 mm	+4.35 mm	+82.5%
BMO Bank of Montreal	4.21 mm	+4.21 mm	NEW
FMR	117.88 mm	+4.11 mm	+3.6%
OMERS ADMINISTRATION	0.00	-4.11 mm	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

BSX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
20 Sep 23	Joseph Michael Fitzgerald	Common Stock	Sell	Dispose S	No	Yes	55	15,867	872.69 k	197,992
15 Sep 23	Wendy Carruthers	Common Stock	Sell	Dispose S	No	Yes	53.9537	11,671	629.69 k	57,058
15 Sep 23	Wendy Carruthers	Common Stock	Option exercise	Acquire M	No	Yes	13.08	2,960	38.72 k	68,729
15 Sep 23	Wendy Carruthers	Common Stock	Option exercise	Acquire M	No	Yes	16.31	3,448	56.24 k	65,769
15 Sep 23	Wendy Carruthers	Stock Option Common Stock	Option exercise	Dispose M	No	Yes	13.08	2,960	38.72 k	8,879
15 Sep 23	Wendy Carruthers	Stock Option Common Stock	Option exercise	Dispose M	No	Yes	16.31	3,448	56.24 k	10,346
12 Sep 23	Michael F Mahoney	Common Stock	Sell	Dispose S	No	Yes	53.9054	113,355	6.11 mm	1,498,922
12 Sep 23	Michael F Mahoney	Common Stock	Option exercise	Acquire M	No	Yes	16.31	55,675	908.06 k	1,612,277
12 Sep 23	Michael F Mahoney	Common Stock	Option exercise	Acquire M	No	Yes	13.08	57,680	754.45 k	1,556,602
12 Sep 23	Michael F Mahoney	Stock Option Common Stock	Option exercise	Dispose M	No	Yes	13.08	57,680	754.45 k	115,361